German company Jennewein Biotechnologie recently announced the introduction of a total biosynthesis approach to produce human milk oligosaccharides (HMOs), including 2'-fucosyllactose (2'-FL). In late 2017, the company obtained the EU...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 (0) 20-3460840
For APAC (Singapore)